Delivery Order SPE2DX22D0010-SPE2D825FGV21
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PERCOCET TABS 10/325, a pain management medication, to support federal medical supply requirements. The contract has a ceiling value of $24,273.95 and is a firm fixed-price delivery order with an ultimate completion date of June 25, 2025. The contract is not set-aside....
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Percocet Tablets (10/325 mg) with a ceiling value of $23,778.44. This competitively awarded, firm fixed-price delivery order is classified as a child contract and represents a non-set-aside procurement. The place of performance is located at the contractor's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 29,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,045.64, is for the supply of Percocet tablets (10/325 mg) to support federal healthcare programs. The award is associated with AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Percocet tablets (10/325 mg) to the U.S. government. The contract is a Delivery Order with a Firm Fixed Price of $37,395.50 and a performance period ending on May 27, 2025. The contract was awarded on May 23, 2025 by the Defense Logistics Agency (DLA), a defense agency. Amerisourcebergen is the prime contractor, and there is no set-aside designation, indicating open competition....
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Percocet tablets (10/325 mg) with a ceiling value of $41,430.55 under a firm fixed-price contract. The award was made on April 24, 2025, with an ultimate completion date of April 25, 2025, and represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Percocet tablets (10/325 mg) with a ceiling value of $20,054.90. This firm fixed-price delivery order, which must be completed by August 28, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the prime contractor, for the supply of Percocet 10-325 mg tablets. The award has a ceiling value of $139,822.85 and a period of performance through April 4, 2024. It is a firm fixed price contract. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. This award is a task order under a larger...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, with a ceiling value of $29,175.70, is for the provision of Percocet tablets (10 mg/325 mg). This is a delivery order contract with a firm fixed price pricing type. The contract has an ultimate completion date of April 22, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $16,049.71, is a delivery order for the supply of Percocet tablets (10/325 mg) to support federal healthcare programs. The contract has an ultimate completion date of October 16, 2024 and is a firm fixed-price arrangement. Amerisourcebergen has been awarded numerous federal contracts and Indefinite Delivery...
- This is a $20,488.39 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of 4,565,316,244 Percocet tablets (10/325 mg) by August 2, 2024. This order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the supply of a comprehensive range of...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FGV21Delivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Percocet tablets 10/325mg, with a ceiling value of $40,711.25 and a completion date of July 9, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order contract is likely part of the larger IDC, enabling Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $40.7k | 7/8/25 |